A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: cyclophosphamide|DRUG: doxorubicin|DRUG: paclitaxel
Sponsor: Duke University
Collaborators: National Cancer Institute (NCI)